S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   10821
 
                           I N  A S S E M B L Y
 
                               July 15, 2020
                                ___________
 
 Introduced  by  COMMITTEE  ON  RULES -- (at request of M. of A. Niou) --
   read once and referred to the Committee on Insurance
 
 AN ACT to amend the insurance law, in relation to capping  cost  sharing
   for insulin
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:

   Section 1. Subparagraph (B) of paragraph 15-a  of  subsection  (i)  of
 section  3216  of the insurance law, as amended by section 1 of part DDD
 of chapter 56 of the laws of 2020, is amended to read as follows:
   (B) Such coverage may be subject to annual deductibles and coinsurance
 as may be deemed appropriate by the superintendent and as are consistent
 with those  established  for  other  benefits  within  a  given  policy;
 provided  however, the total amount that a covered person is required to
 pay out of pocket for covered prescription insulin drugs shall be capped
 at an amount not to exceed [one hundred] THIRTY dollars  per  thirty-day
 supply,  regardless of the amount or type of insulin needed to fill such
 covered person's prescription and regardless of  the  insured's  deduct-
 ible, copayment, coinsurance or any other cost sharing requirement.
   § 2. Subparagraph (B) of paragraph 7 of subsection (k) of section 3221
 of  the insurance law, as amended by section 2 of part DDD of chapter 56
 of the laws of 2020, is amended to read as follows:
   (B) Such coverage may be subject to annual deductibles and coinsurance
 as may be deemed appropriate by the superintendent and as are consistent
 with those  established  for  other  benefits  within  a  given  policy;
 provided  however, the total amount that a covered person is required to
 pay out of pocket for covered prescription insulin drugs shall be capped
 at an amount not to exceed [one hundred] THIRTY dollars  per  thirty-day
 supply,  regardless of the amount or type of insulin needed to fill such
 covered person's prescription and regardless of  the  insured's  deduct-
 ible, copayment, coinsurance or any other cost sharing requirement.
   §  3.  Paragraph  2 of subsection (u) of section 4303 of the insurance
 law, as amended by section 3 of part DDD of chapter 56 of  the  laws  of
 2020, is amended to read as follows:
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
              

                                                            LBD16178-01-0

 A. 10821                            2
 
   (2) Such coverage may be subject to annual deductibles and coinsurance
 as may be deemed appropriate by the superintendent and as are consistent
 with  those  established  for  other  benefits  within  a  given policy;
 provided however, the total amount that a covered person is required  to
 pay out of pocket for covered prescription insulin drugs shall be capped
 at  an  amount not to exceed [one hundred] THIRTY dollars per thirty-day
 supply, regardless of the amount or type of insulin needed to fill  such
 covered  person's  prescription  and regardless of the insured's deduct-
 ible, copayment, coinsurance or any other cost sharing requirement.
   § 4. This act shall take effect immediately and  shall  apply  to  any
 policy or contract issued or renewed on or after January 1, 2021.